1. Dengvaxia: risk of severe disease without prior dengue exposure

   News item 16 December 2017 Pages: 1 - 1

2. EMA's monitoring list to be adopted in Arab countries

   News item 16 December 2017 Pages: 2 - 2

3. EMA's PRAC meeting highlights from Nov 2017

   News item 16 December 2017 Pages: 3 - 3

4. Healthcare professionals warned of PML risk with cladribine

   Correspondence 16 December 2017 Pages: 4 - 4

5. Package insert revisions recommended by PMDA

   News item 16 December 2017 Pages: 5 - 5

6. Risk of metabolic acidosis with flucloxacillin + paracetamol

   News item 16 December 2017 Pages: 6 - 6

7. UK's MHRA targets online sale of fake slimming pills

   News item 16 December 2017 Pages: 7 - 7

8. Voluntary recall of Limbrel capsules recommended

   News item 16 December 2017 Pages: 8 - 8

9. Bleeding management Expert Consensus Decision Pathway

   Guideline 16 December 2017 Pages: 9 - 9

10. Breast cancer with contemporary hormonal contraception

    Clinical study 16 December 2017 Pages: 10 - 10

11. NHPA: drug interaction experiences in older adults

    News item 16 December 2017 Pages: 11 - 11

12. Suicide in CNS drug users: branded vs generic

    Clinical study 16 December 2017 Pages: 12 - 12

13. Thromboembolic-related events with JAK inhibitors

    Clinical study 16 December 2017 Pages: 13 - 13

14. Plantago ovata

    Case report 16 December 2017 Pages: 14 - 14

15. Abiraterone

    Case report 16 December 2017 Pages: 15 - 15

16. Acetylcysteine

    Case report 16 December 2017 Pages: 16 - 16

17. Acetylcysteine/epoprostenol/heparin

    Case report 16 December 2017 Pages: 17 - 17

18. Adalimumab

    Case report 16 December 2017 Pages: 18 - 18

19. Adalimumab

    Case report 16 December 2017 Pages: 19 - 19

20. Adalimumab/certolizumab pegol/infliximab

    Case report 16 December 2017 Pages: 20 - 20

21. Adalimumab/etanercept

    Case report 16 December 2017 Pages: 21 - 21

22. Adalimumab/etanercept/infliximab

    Case report 16 December 2017 Pages: 22 - 22

23. Albendazole

    Case report 16 December 2017 Pages: 23 - 23

24. Alectinib

    Case report 16 December 2017 Pages: 24 - 24

25. Alemtuzumab

    Case report 16 December 2017 Pages: 25 - 25

26. Alendronic-acid

    Case report 16 December 2017 Pages: 26 - 26

27. Allopurinol/azathioprine

    Case report 16 December 2017 Pages: 27 - 27

28. Aluminium potassium sulfate/tannic acid

    Case report 16 December 2017 Pages: 28 - 28

29. Aminocaproic acid

    Case report 16 December 2017 Pages: 29 - 29

30. Amiodarone

    Case report 16 December 2017 Pages: 30 - 30

31. Amphotericin-B liposomal/fluconazole

    Case report 16 December 2017 Pages: 31 - 31

32. Antibacterials

    Case report 16 December 2017 Pages: 32 - 32

33. Antibacterials

    Case report 16 December 2017 Pages: 33 - 33

34. Antibacterials/paracetamol

    Case report 16 December 2017 Pages: 34 - 34

35. Antihyperlipidaemics

    Case report 16 December 2017 Pages: 35 - 35

36. Antineoplastic drugs

    Case report 16 December 2017 Pages: 36 - 36

37. Antineoplastics

    Case report 16 December 2017 Pages: 37 - 37

38. Antineoplastics

    Case report 16 December 2017 Pages: 38 - 38

39. Antineoplastics

    Case report 16 December 2017 Pages: 39 - 39

40. Antineoplastics

    Case report 16 December 2017 Pages: 40 - 40

41. Antipsychotics

    Case report 16 December 2017 Pages: 41 - 41

42. Antiretrovirals/immunosuppressants interactions

    Case report 16 December 2017 Pages: 42 - 42

43. Antithymocyte globulin

    Case report 16 December 2017 Pages: 43 - 43

44. Antivirals

    Case report 16 December 2017 Pages: 44 - 44

45. Apatinib

    Case report 16 December 2017 Pages: 45 - 45

46. Apatinib

    Case report 16 December 2017 Pages: 46 - 46

47. Apatinib/gemcitabine/paclitaxel

    Case report 16 December 2017 Pages: 47 - 47

48. Apomorphine

    Case report 16 December 2017 Pages: 48 - 48

49. Aripiprazole

    Case report 16 December 2017 Pages: 49 - 49

50. Aripiprazole/clomipramine/risperidone

    Case report 16 December 2017 Pages: 50 - 50